These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 35044859)
1. Myeloid mineralocorticoid receptors contribute to skeletal muscle repair in muscular dystrophy and acute muscle injury. Howard ZM; Rastogi N; Lowe J; Hauck JS; Ingale P; Gomatam C; Gomez-Sanchez CE; Gomez-Sanchez EP; Bansal SS; Rafael-Fortney JA Am J Physiol Cell Physiol; 2022 Mar; 322(3):C354-C369. PubMed ID: 35044859 [TBL] [Abstract][Full Text] [Related]
2. Alterations in Notch signalling in skeletal muscles from mdx and dko dystrophic mice and patients with Duchenne muscular dystrophy. Church JE; Trieu J; Chee A; Naim T; Gehrig SM; Lamon S; Angelini C; Russell AP; Lynch GS Exp Physiol; 2014 Apr; 99(4):675-87. PubMed ID: 24443351 [TBL] [Abstract][Full Text] [Related]
3. Identification and Function of Fibrocytes in Skeletal Muscle Injury Repair and Muscular Dystrophy. Wang X; Zhao W; Ransohoff RM; Zhou L J Immunol; 2016 Dec; 197(12):4750-4761. PubMed ID: 27913649 [TBL] [Abstract][Full Text] [Related]
5. Mineralocorticoid receptor antagonists and glucocorticoids differentially affect skeletal muscle inflammation and pathology in muscular dystrophy. Howard ZM; Gomatam CK; Rabolli CP; Lowe J; Piepho AB; Bansal SS; Accornero F; Rafael-Fortney JA JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040807 [TBL] [Abstract][Full Text] [Related]
6. Myeloid cells are capable of synthesizing aldosterone to exacerbate damage in muscular dystrophy. Chadwick JA; Swager SA; Lowe J; Welc SS; Tidball JG; Gomez-Sanchez CE; Gomez-Sanchez EP; Rafael-Fortney JA Hum Mol Genet; 2016 Dec; 25(23):5167-5177. PubMed ID: 27798095 [TBL] [Abstract][Full Text] [Related]
7. Changes in calsequestrin, TNF-α, TGF-β and MyoD levels during the progression of skeletal muscle dystrophy in mdx mice: a comparative analysis of the quadriceps, diaphragm and intrinsic laryngeal muscles. Barros Maranhão J; de Oliveira Moreira D; Maurício AF; de Carvalho SC; Ferretti R; Pereira JA; Santo Neto H; Marques MJ Int J Exp Pathol; 2015 Oct; 96(5):285-93. PubMed ID: 26515458 [TBL] [Abstract][Full Text] [Related]
8. Fibrosis and inflammation are greater in muscles of beta-sarcoglycan-null mouse than mdx mouse. Gibertini S; Zanotti S; Savadori P; Curcio M; Saredi S; Salerno F; Andreetta F; Bernasconi P; Mantegazza R; Mora M Cell Tissue Res; 2014 May; 356(2):427-43. PubMed ID: 24723230 [TBL] [Abstract][Full Text] [Related]
9. Mineralocorticoid Receptor Signaling Contributes to Normal Muscle Repair After Acute Injury. Hauck JS; Howard ZM; Lowe J; Rastogi N; Pico MG; Swager SA; Petrosino JM; Gomez-Sanchez CE; Gomez-Sanchez EP; Accornero F; Rafael-Fortney JA Front Physiol; 2019; 10():1324. PubMed ID: 31736768 [TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid Receptor Signaling in the Inflammatory Skeletal Muscle Microenvironments of Muscular Dystrophy and Acute Injury. Howard ZM; Gomatam CK; Piepho AB; Rafael-Fortney JA Front Pharmacol; 2022; 13():942660. PubMed ID: 35837290 [TBL] [Abstract][Full Text] [Related]
15. Cell-type specific effects of mineralocorticoid receptor gene expression suggest intercellular communication regulating fibrosis in skeletal muscle disease. Gomatam CK; Ingale P; Rodriguez G; Munger S; Pomeranets R; Krishna S; Lowe J; Howard ZM; Rafael-Fortney JA Front Physiol; 2024; 15():1322729. PubMed ID: 38737833 [No Abstract] [Full Text] [Related]
16. Decrease of myofiber branching via muscle-specific expression of the olfactory receptor mOR23 in dystrophic muscle leads to protection against mechanical stress. Pichavant C; Burkholder TJ; Pavlath GK Skelet Muscle; 2016; 6():2. PubMed ID: 26798450 [TBL] [Abstract][Full Text] [Related]
17. Temporal gene expression profiling of dystrophin-deficient (mdx) mouse diaphragm identifies conserved and muscle group-specific mechanisms in the pathogenesis of muscular dystrophy. Porter JD; Merriam AP; Leahy P; Gong B; Feuerman J; Cheng G; Khanna S Hum Mol Genet; 2004 Feb; 13(3):257-69. PubMed ID: 14681298 [TBL] [Abstract][Full Text] [Related]
18. Skeletal muscle fibrosis in the mdx/utrn+/- mouse validates its suitability as a murine model of Duchenne muscular dystrophy. Gutpell KM; Hrinivich WT; Hoffman LM PLoS One; 2015; 10(1):e0117306. PubMed ID: 25607927 [TBL] [Abstract][Full Text] [Related]
19. Similar efficacy from specific and non-specific mineralocorticoid receptor antagonist treatment of muscular dystrophy mice. Lowe J; Floyd KT; Rastogi N; Schultz EJ; Chadwick JA; Swager SA; Zins JG; Kadakia FK; Smart S; Gomez-Sanchez EP; Gomez-Sanchez CE; Raman SV; Janssen PM; Rafael-Fortney JA J Neuromuscul Dis; 2016; 3(3):395-404. PubMed ID: 27822449 [TBL] [Abstract][Full Text] [Related]